What Does NxGen MDx Screen For?
We screen for up to 120 genetic disorders that can affect your pregnancy, the health of your baby, and your family's future. You can learn more about our various screens — and which sets of screens (or "panels") align with where you are in your reproductive journey.
Glycogen Storage Disease Type 1a
What Your Test Results Mean:
Carriers typically show no symptoms of glycogen storage disease type 1A; however, carriers are at an increased risk of having a child with glycogen storage disease type 1A. Risk for the current or future pregnancies is dependent on your partner’s carrier status.
Glycogen storage disease type 1A is an inherited metabolic disorder in which harmful amounts of glycogen and fat accumulate in the liver and kidneys. Individuals with glycogen storage disease type 1A do not produce enough of one of the enzymes, glucose-6-phosphatase. This enzyme is needed to metabolize glucose-6-phosphate into glucose. Lack of this enzyme causes severe hypoglycemia that can lead to seizures and brain damage. Some infants with glycogen storage disease type 1A present with severe hypoglycemia while others present at three to four months of age with hepatomegaly, lactic acidosis, and/or seizures. Long-term complications of untreated disease include neurocognitive symptoms, anemia, short stature, osteoporosis, delayed puberty, gout, renal disease, and pancreatisis, and risk for hepatocellular carcinoma later in life. Many affected individuals live into adulthood with appropriate treatment with normal growth and puberty.
Treatment of individuals with glycogen storage disease type 1A typically includes care by a metabolic team, specifically to monitor medical complications and nutrition. A diet low in fructose and sucrose, overnight glucose infusion, cornstarch therapy, and frequent daytime feedings may be recommended in an effort to prevent hypoglycemia. Liver transplantation has been used in individuals with glycogen storage disease type 1A to restore metabolic balance and reduce the risk for hepatocellular carcinoma.
How the Genetics Works:
The clinical features of glycogen storage disease type 1A can be explained by pathogenic variants in the G6PC gene. In general, individuals have two copies of the G6PC gene. Carriers of glycogen storage disease type 1A have a single variant in one copy of the G6PC gene, while individuals with glycogen storage disease type 1A have variants in both copies of their G6PC genes, one inherited from each parent.
Talk to a Genetic Counselor
As a NxGen client, you'll have access to personal genetic counselors who can help explain the results of your screens and provide insight on how to move forward. To schedule a personal conference to discuss your screen results, call (855) 776-9436. or click the link below.Discuss Your Screening Results